Evaluation of the Effects of Sequential Multiple- Dose Regimens of Levomilnacipran Er on Cardiac Repolarization in Healthy Subjects.
Phase of Trial: Phase I
Latest Information Update: 09 Apr 2014
At a glance
- Drugs Levomilnacipran (Primary) ; Moxifloxacin
- Indications Major depressive disorder; Stroke
- Focus Adverse reactions
- Sponsors Forest Laboratories
- 09 Apr 2014 New trial record
- 22 Mar 2014 Results presented at the 115th Annual Meeting of the American Society for Clinical Pharmacology and Therapeutics.